NEW YORK, Feb. 28, 2005 (PRIMEZONE) -- Advance Nanotech Inc. (OTCBB:AVNA), a company that specializes in the acquisition and commercialization of nanotechnologies, announced today its sponsorship of the annual Milken Institute Global Conference, taking place April 18-April 20, 2005 at the Beverly Hilton Hotel in Los Angeles, CA. The conference draws together more than 2,000 senior decision makers from industry, government, financial institutions, and philanthropy from over 50 countries to discuss and debate ideas about how to solve some of the world's most pressing challenges.
"Nanotechnology will have far reaching effects throughout society," stated Stephanie Interbartolo, Sr. Vice President, Business Development of Advance Nanotech. "These effects will present opportunities but also challenges to industry and government. We are pleased to be sponsoring the Milken Institute Global Conference so that we may discuss this emerging industry within a forum of key decision makers from business, government and academia."
Advance Nanotech is a proponent of funding university development programs as the first step in new product creation. Among the topics to be discussed at this year's conference will be the value of university-based research and its subsequent commercialization.
This year's conference, "Building a Prosperous Future," will also examine such issues as the global investment climate; and the latest economic developments in Europe, Asia, Russia, Latin America and the U.S.
Among confirmed speakers at the conference are former Vice President Al Gore; Rupert Murdoch, Chairman and CEO, News Corporation; Terry Semel, Chairman and CEO, Yahoo!; Charlene Barshefsky, former U.S. Trade Representative; Mel Karmazin, CEO, SIRIUS Satellite Radio; Steve Forbes, President and CEO, Forbes; William Haseltine, former CEO, Human Genome Sciences; Douglas Holtz-Eakin, Director, Congressional Budget Office; Jonathan Miller, Chairman and CEO, AOL; Mike Milken, Chairman of FasterCures and the Milken Institute; Steve Wynn, President and CEO, Wynn Resorts; Sam Zell, Chairman, Equity Group Investments; and more than 200 others.
For complete information about the 2005 Global Conference, go to: http://www.milkeninstitute.org/gc2005.
About Advance Nanotech Inc.
Advance Nanotech, Inc. ("Advance") commercializes innovative nanotechnologies. Operating in three areas, electronics, biopharma and materials, Advance leverages relationships with financial and development resources to enable a product focused fast-track commercialization of nanotechnology. Advance has established relationships with academic institutions throughout the world that are at the forefront of nanotechnology research and development. Advance's objective is to invest in patented innovation to bridge early stage product development with valuable markets. Advance Nanotech is quoted on the Over-The-Counter Bulletin Board under the symbol "AVNA.OB." For more information on Advance Nanotech, visit the company's website at http://www.advancenanotech.com.
About the Milken Institute
The Milken Institute is a nonprofit, independent economic think tank whose mission is to improve the lives and economic conditions of diverse populations around the world by helping business and public policy leaders identify and implement innovative ideas for creating broad-based prosperity. It is based in Santa Monica, CA. (http://www.milkeninstitute.org)
Advance Nanotech Safe Harbor Statement
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with those inherent in the early stage of Advance Nanotech's technologies under development; acquisitions, divestitures, mergers, licenses or strategic initiatives that change Advance Nanotech's business, structure or projections; the development of competing products; uncertainties related to Advance Nanotech's dependence on third parties and partners, and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Advance Nanotech, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.